Zealand Pharma A/S (ZEAL) — Cash Flow Reinvestment Rate
Zealand Pharma A/S (ZEAL) has a Cash Flow Reinvestment Rate of 0.19x as of June 2025, reinvesting Dkr1.58 Billion (capex Dkr6.73 Million plus investments Dkr-1.57 Billion) from operating cash flow of Dkr8.52 Billion. Explore ZEAL capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zealand Pharma A/S Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Zealand Pharma A/S across 3 annual periods. Also explore ZEAL asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zealand Pharma A/S (2012–2025)
Year-by-year capital reinvestment analysis for Zealand Pharma A/S. For live market cap and broader valuation context, see Zealand Pharma A/S market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | Dkr33.37 Million | Dkr6.53 Billion | Dkr33.37 Million | ▼ -99.9% |
| 2016 | 7.40x | Dkr302.56 Million | Dkr40.90 Million | Dkr2.60 Million | ▲ +5628.9% |
| 2012 | 0.13x | Dkr8.85 Million | Dkr68.54 Million | Dkr8.85 Million | — |